Dr. Nikhil S Ghadyalpatil

Education Qualifications

• 2023: Advanced Certification in Molecular Oncology (ACMO)
• 2020: MRCP (SCE - Medical Oncology)
• 2007-2013: European Certification in Medical Oncology
• 2006-2009: DM (Medical Oncology), Tata Memorial Hospital, Mumbai
• 2006: Diplomate of National Board (DNB), Seth G. S. Medical College and KEM Hospital, Mumbai
• 2003-2006: MD (Internal Medicine), Seth G. S. Medical College and KEM Hospital, Mumbai
• 1996-2001: MBBS, Government Medical College, Nagpur

Experience

• April 2010-Present: Director - Medical Oncology, Senior Consultant Medical Oncologist & Hemato-Oncologist, Yashoda Hospitals, Somajiguda
• 2009-2010: Ad-Hoc Consultant Medical Oncology, Tata Memorial Center

Services offered

• Cancer Treatment/Therapies in Medical Oncology
• Chemotherapy
• Targeted Therapy
• Precision Oncology
• Head and Neck Cancer Treatment (Oral Cancer/Buccal Mucosa Cancer/Throat Cancer/Larynx Cancer/Hypopharynx Cancer)
• Solid Tumors (Breast Cancer, Lung Cancer, Gastrointestinal Cancers (Pancreatic Cancer, Gallbladder Cancer, Colon/Intestinal Cancer), Sarcoma, Bone Cancer, Gynecological Cancers (Cervical Cancer, Uterine Cancer, Ovarian Cancer), Genitourinary Cancer (Testicular Cancer, Bladder Cancer, Prostate Cancer)), Management of Brain Tumors
• Medical Oncology
• Pediatric Oncology/Childhood Cancers
• Supportive and Palliative Care
• Cancer Nutrition
• Cancer Survivorship
• Personalised Therapy
• Genomics Directed Therapy
• Immunotherapy (Immuno Oncology)
• Cancer Prevention
• Holistic Cancer Care

Special Interest and Expertise

• Geriatric Oncology
• Immunotherapy
• Targeted Theraphy, Precision Oncology, Molecular Oncology
• Hematological Malignancies/Blood Cancers/Lymphoma/Leukemia/Multiple Myeloma
• Solid Tumors
• Pediatric Oncology
• Cancer Nutrition

Professional Membership

• American Society of Clinical Oncology (ASCO)
• European Society of Clinical Oncology (ESMO)
• Indian Society of Medical and Pediatric Oncology (ISMPO)
• Indian Cooperative Oncology Network (ICON)

Research & Publications

• Purvish M. Parikh, Sachin Hingmire, Nikhil Ghadyalpatil. Next Wave of COVID-19: Lessons for India from Indonesia, Israel, and Iceland. South Asian J Cancer 2021; 00:1–3
• Ghanshyam Biswas, Avinash Pandey, Nikhil Ghadyalpatil, Nilesh Lokeshwar, Boben Thomas, Anita Ramesh,Yogesh Arora, Chandragouda Dodagoudar, Vibha Naik, Ashish Joshi, Indranil Ghosh, Rakesh Roy, Medhi Kunjahari, Tejinder Singh, Palanki Dattatreya Satya, Sachin Hingmire, Purvish M Parikh. Role of Cresp® in the management of chemotherapy‑induced anemia in cancer patients: A real‑world clinical practice audit. South Asian J Cancer 2020; 9:59-61
• Purvish M. Parikh, P. Narayanan, A. Vora, A. Gulia, S. K. Mullapally, B. Rangrajan, S. Gupta, P. Mehta, S. Hingmire, P. Kulkarni, B. Parekh, N. Ghadyalpatil, G. Babu, R. Singh. Conflict of interest disclosure and interpretation - rest assured the medical professional in the audience is perceptive, alert and smart. Indian J Med Sci 2019;x(x):1-5
• Bhavesh Parekh, N. Ghadlyalpatil, E. V. Chandarana, S. S. Hingmire, Gupta Sumant, V. Agarwala, A. Tiwari, G. S. Bhattacharyya, P. M. Parikh. Immunotherapy in esophageal cancer – An update. International Journal of Molecular & Immuno Oncology, Volume 4, Issue 2, September-December 2019
• Ghadyalpatil NS, Pandey A, Krishnamani I, Srinivas C, Rafiq SJ, Hingmire SS, et al. First-line management of metastatic non-small cell lung cancer: An Indian perspective. South Asian J Cancer 2019; 8:73-9
• Parikh P M, Bhattacharyya G S, Hingmire S S, Mehta P, Rangrajan B, Ganesh Natrajan, Ghadyalpatil N, Narayanan P, Singh Randeep, Parekh Bhavesh, Singhal M. “Our patient at risk from unauthorized, unapproved, illegally imported fake "generic medicines”. Indian Journal of Medical Science 2018 September-December;70(3):43-47
• Parikh PM, Bhattacharyya GS, Hingmire SS, Kulkarni P, Eswaran P, Jhaveri KK, Gandhi PA, Mehta P, Babu G, Rangrajan B, Ghadyalpatil N, Bahl A, Narayanan P. Consent from new patient at first registration, Indian Journal of Medical Science 2018 April: June;70(2):29-33
• Reena Nair, Abhishek Kakroo, Ajay Bapna, Ajay Gogia, Amish Vora, Anand Pathak, Anu Korula, Anupam Chakrapani, Dinesh Doval, Gaurav Prakash, Ghanashyam Biswas, Hari Menon, Maitreyee Bhattacharya, Mammen Chandy, Mayur Parihar, M. Vamshi Krishna, Neeraj Arora, Nikhil Gadhyalpatil, Pankaj Malhotra, Prasad Narayanan, Rekha Nair, Rimpa Basu, Sandip Shah, Saurabh Bhave, Shailesh Bondarde, Shilpa Bhartiya, Soniya Nityanand, Sumeet Gujral, T. V. S. Tilak, Vivek Radhakrishnan. Management of Lymphomas: Consensus Document 2018 by an Indian Expert Group, Indian J Hematol Blood Transfus (July-Sept 2018) 34(3):398–421
• Babu G, Bahl A, Bhattacharya GS, Bhowmik KT, Dattatraya PS, Ghadyalpatil N, et al. Oncology gold standard® practical consensus recommendations for the use of monoclonal antibodies in the management of squamous cell carcinoma of head and neck. South Asian J Cancer 2017; 6:154-60
• Purvish M. Parikh, S. S. Hingmire, P. Bhavesh, K. Babu Govind, P. Mehta, A. Verma, S. Bondarde, R. Singh, N. Ghadyalpatil, B. Rangrajan, G. S. Bhattacharyya, H. Malhotra, D. C. Doval, A. A. Ranade, P. M. Shah. Oncology Gold Standard™ consensus statement on counseling patients for molecular testing and personalized cancer care. Int J Mol ImmunoOncol 2017; 2:1-11
• Under the aegis of Lung Cancer Consortium Asia (LCCA), Indian Cooperative Oncology Network (ICON), Indian Society of Medical & Pediatric Oncology (ISMPO), Molecular Oncology Society (MOS) and Association of Physicians of India API). Indian consensus statement for treatment of advanced non-small cell lung cancer: First line, maintenance, and second line. Indian Journal of Cancer | Volume 54 | Issue 1 | January-March 2017
• Vedang Murthy, Adnan Calcuttawala, Kirti Chadha, Anil d'Cruz, Arvind Krishnamurthy, Indranil Mallick, Sudhir Nair, Tanuja Teni, Sagar Pawar, Kaustav Talapatra, Asawari Patil, Amit Bhatt, Sanjoy Chatterjee, Monali Swain, Prasad Narayanan, Nikhil Ghadyalpatil, Manish Singhal, Moni Kuriakose, Kumar Prabhash, Jaiprakash Agarwal, Purvish Parikh. Human papillomavirus in head and neck cancer in India: Current status and consensus recommendations. South Asian Journal of Cancer, Year 2017, Volume 6, Issue 3 [p. 93-98]
• U Batra, PM Parikh, K Prabhash, HB Tongaonkar, and Expert Group Members, P Chibber, D Dabkara, C Deshmukh, N Ghadyalpatil, S Hingmire, A Joshi, SK Raghunath, S Rajappa, R Rajendranath, SK Rawal, Manisha Singh, R Singh, SP Somashekhar, and R Sood. Oncology Gold Standard™ practical consensus recommendations 2016 for treatment of advanced clear cell renal cell carcinoma. South Asian J Cancer. 2016 Oct-Dec; 5(4): 167–175
• Patil V, Noronha V, Joshi A, Parikh P, Bhattacharjee A, Chakraborty S, Jandyal S, Muddu V, Ramaswamy A, Babu KG, Lokeshwar N, Hingmire S, Ghadyalpatil N, Banavali S, Prabhash K. Survey of Implementation of Antiemetic Prescription Standards in Indian Oncology Practices and Its Adherence to the American Society of Clinical Oncology Antiemetic Clinical Guideline. J Glob Oncol. 2016 Nov 9;3(4):346-359
• Ghadyalpatil NS, Chopra S, Patil P, et al. Gastrointestinal Cancers in India: Treatment perspective. South Asian J Cancer. 2016; 5:126–36.
• P. M. Parikh, A. A. Ranade, Babu Govind, N. Ghadyalpatil, R. Singh, R. Bharath, G. S. Bhattacharyya, S. Koyande, M. Singhal, A. Vora, A. Verma, and S. Hing. Lung cancer in India: Current status and promising strategies. South Asian J Cancer. 2016 Jul-Sep; 5(3): 93–95
• Kumar P, Bajpai J1, Shetty N, Medekar A, Kurkure PA, Ghadyalpatil N, Gupta S, Noronha V, Kanujia A, Parikh P, Banavali SD. Management of febrile neutropenia in malignancy using the MASCC score and other factors: Feasibility and safety in routine clinical practice. Indian J Cancer. 2014 Oct-Dec;51(4):491-5
• Kumar P, Medhekar A, Ghadyalpatil NS, Noronha V, Biswas S, Kurkure P, Nair R, Kelkar R, Banavali SD. The effect of age on the bacteria isolated and the antibiotic-sensitivity pattern in infections among cancer patients. Indian J Cancer. 2010 Oct Dec;47(4):391-6.
• Prabhash K, Medhekar A, Ghadyalpatil N, Noronha V, Biswas S, Kurkure P, Nair R, Kelkar R. Blood stream infections in cancer patients: a single center experience of isolates and sensitivity pattern. Indian J Cancer. 2010 Apr-Jun;47(2):184-8
• Mardikar HM, Deshpande NV, Ghadyalpatil NS, Mardikar M. Patent protection: a need for value-based patents. Lancet 2003 Feb 15;361(9357):613
• Purvish M. Parikh, S. S. Hingmire, P. Bhavesh, K. Babu Govind, P. Mehta, A. Verma, S. Bondarde, R. Singh, N. Ghadyalpatil, B. Rangrajan, G. S. Bhattacharyya, H. Malhotra, D. C. Doval, A. A. Ranade, P. M. Shah. Oncology Gold Standard™ consensus statement on counseling patients for molecular testing and personalized cancer care. Int J Mol ImmunoOncol 2017;2:1-11 ● Under the aegis of Lung Cancer Consortium Asia (LCCA), Indian Cooperative Oncology Network (ICON), Indian Society of Medical & Pediatric Oncology (ISMPO), Molecular Oncology Society (MOS) and Association of Physicians of India API). Indian consensus statement for treatment of advanced non small cell lung cancer: First line, maintenance, and second line. Indian Journal of Cancer | Volume 54 | Issue 1 | January-March 2017 (Co Author)
• Kumar P, Bajpai J, Shetty N, Medekar A, Kurkure PA, Ghadyalpatil N, Gupta S, Noronha V, Kanujia A, Parikh P, Banavali SD. Management of febrile neutropenia in malignancy using the MASCC score and other factors: Feasibility and safety in routine clinical practice. Indian J Cancer. 2014 Oct-Dec;51(4):491-5
• Ghadyalpatil NS, R Chandrasekar, D Snehalatha, BM Reddy. A case of primary ovarian lymphoma with autoimmune hemolytic anaemia achieving complete response with Rituximab-based combination chemotherapy. IJMPO Oct-Dec 2011. Volume 32, Issue 4.207-210
• Books Authored
  • Chapter on Neoadjuvant Systemic Therapy in Breast Cancer: Current Perspectives in Strategies for Breast Cancer Management: Expert Reviews, an educational handbook 2019.
  • Thrombosis and Cancer. Sudeep Gupta, Nikhil Ghadyalpatil, Gautam Goyal. Evidence Based Management of Cancers in India. (Co-author)
  • All about Stents and PORTs. Navin Khattry, Nikhil Ghadyalpatil. Hematology 2008 (Book By Dr. M.B Agrawal)
• Reviewer and Editor
  • Executive Editor, South Asian Journal of Cancer
  • International Journal of Cancer (IJC)
  • Indian Journal of Medical and Paediatric Oncology (IJMPO)
  • South Asian Journal of Cancer (SAJC)

Awards and Achievements

• MRCP SCE 2020 UK
• ASCO-International Development and Education Award (IDEA), Karmanos Cancer Center, Wayne State University, Detroit, 2010
• DM Medical Oncology (1st Rank, Tata Memorial, Mumbai) 2009
• European Certification in Medical Oncology (ECMO), Barcelona, Spain, 2007
• Gold Medal for Securing First Position in PG Examination from KEMH, Mumbai, India, 2006
• B Braun Foundation Scholarship (National Scholarship) for Outstanding Performance during PG, 2003
• Nagpur University Medal and Prize-Topper in Physiology, 1997

  FAQ'S

1. 1. Why do patients frequently visit Dr. Nikhil S Ghadyalpatil?
   

   Patients visit Dr. Nikhil S Ghadyalpatil to receive treatment for various cancers.

2. 2. What is Dr. Nikhil S Ghadyalpatil's educational qualification?
   

   Dr. Nikhil S Ghadyalpatil holds the following qualifications: MD (Gen Med), DNB (G. Med), DM (Medical Oncology).

3. 3. What does Dr. Nikhil S Ghadyalpatil specialise in?
   

   Dr. Nikhil S Ghadyalpatil is the Director of Medical Oncology and Senior Consultant Medical Oncologist & Hemato-Oncologist who specialises in Immunotherapy, Hematological Malignancies, Solid Tumors, Pediatric Oncology, and Cancer Nutrition, among others.

4. 4. Where does Dr. Nikhil S Ghadyalpatil practice?
   

   Dr. Nikhil S Ghadyalpatil practices at Yashoda Hospitals, Somajiguda.

5. 5. How can I book Dr. Nikhil S Ghadyalpatil’s appointment?
   

   You can schedule an appointment with Dr. Nikhil S Ghadyalpatil for both an Online Video Consultation and an OPD Consultation by visiting his profile on Yashoda Hospitals.